News

Formus Labs is pleased to announce that internationally regarded, Oxford-trained orthopaedic surgeon, Dr. George Grammatopoulos, has joined our growing clinical advisory board. Dr. Grammatopoulos will provide expert feedback on ongoing clinical evaluations and further development of Formus Labs’ AI-automated 3D pre-operative planning software.

Formus CEO Ju Zhang on some of the challenges and opportunities facing us over the next 12 months and beyond.

A recently opened top-up round has further strengthened Formus Labs’ long-term capital outlook, despite the COVID-19 pandemic.

Formus Labs has begun formal clinical evaluations of its world-first personalized planning software for orthopedic surgeons.

As we move forward with clinical evaluations, we’re delighted to add another highly respected practitioner, Nicholas Giori, M.D., Ph.D., to our clinical advisory board.

As a company with global ambition, a recent AANZ-sponsored trip to San Francisco served as the perfect launchpad for expanding our investor network in Silicon Valley.